Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Annales de Dermatologie et de Vénéréologie
Volume 137, n° 4
pages 264-266 (avril 2010)
Doi : 10.1016/j.annder.2010.02.012
How to evaluate the benefit–risk profile of newly marketed drugs
Comment évaluer le rapport bénéfice–risque des médicaments nouvellement commercialisés
 

L. Naldi
Centro Studi GISED, Fondazione per la Ricerca Ospedale Maggiore, Presidio Ospedaliero Matteo Rota, Bergamo, and Unità di Dermatologia, Ospedali Riuniti, Bergamo, Italy 



© 2010  Elsevier Masson SAS. All Rights Reserved.